
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
SR-2A CRISPR/Cas9 KO Plasmid (h) | sc-401532 | 20 µg | $397.00 |
HTR2A encodes the human 5-hydroxytryptamine receptor 2A (SR-2A), a G protein–coupled receptor that primarily couples to Gq/11 to stimulate phospholipase C signaling, inositol phosphate turnover, intracellular Ca²⁺ mobilization, and protein kinase C activation. SR-2A modulates neuronal excitability and synaptic plasticity and interfaces with broader neurotransmitter networks through cross-talk with MAPK/ERK and related second-messenger pathways. Expression and signaling changes in HTR2A are frequently investigated in the context of neuropsychiatric phenotypes, including altered serotonergic tone and receptor-mediated cortical circuit function. As a membrane receptor with complex regulatory dynamics, SR-2A provides a tractable node for dissecting pathway-specific signaling and receptor desensitization/internalization mechanisms in human cellular models.
SR-2A CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the HTR2A gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the HTR2A together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the HTR2A open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish SR-2A protein expression.
This CRISPR knockout system enables efficient generation of HTR2A-deficient cell models for investigation of SR-2A signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.